Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Szerbia

1 trial · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 2. fázisTaking people
  DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  Where

  Belgrade, Kamenitz, Kragujevac, Zemun

  Életkor

  18 év and over

  People

  102 worldwide

  Run by

  ImmunoVaccine Technologies, Inc. (IMV Inc.)

  See details and how to joinNCT04920617